| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
We investigated the role of intracellular pH in protection by propofol of glutamate uptake during oxidative stress. Exposure of primary astrocyte cultures to tert-butylhydroperoxide (t-BOOH, 300 µM) decreased the initial rate of Na-dependent glutamate uptake. Either propofol or -tocopherol, administered 30 min after t-BOOH, attenuated this transport inhibition. These lipophilic antioxidants protected glutamate uptake whether the medium contained 25 mM bicarbonate or was nominally bicarbonate-free. t-BOOH also inhibited Na/H exchanger isoform 1 (NHE1) activation by intracellular protons and propofol prevented this inhibition. Blockade of NHE1 by the potent antagonist, 5-(N-ethyl-N-isopropyl) amiloride (1 µM), abolished the protective effects of small concentrations of propofol (1 µM) and -tocopherol (40 µM) on glutamate uptake during oxidative stress in bicarbonate-free medium. 5-(N-ethyl-N-isopropyl) amiloride had no effect on antioxidant rescue of glutamate transport in medium containing 25 mM bicarbonate. These results indicate that regulation of intracellular pH may contribute to neuroprotection by propofol and other lipophilic antioxidants. Propofol concentrations that are associated with anesthesia and neuroprotection may prevent intracellular acidification during oxidative stress by preserving the NHE1 response to cytosolic protons. However, if intracellular acidification occurs nonetheless, then propofol protection of glutamate uptake activity becomes less effective and the extracellular glutamate concentration may increase to neurotoxic levels. IMPLICATIONS: Anesthetic concentrations of propofol maintain the capacity of brain cells to extrude protons during oxidative stress. However, if intracellular acidification occurs nonetheless, then propofols protection of glutamate clearance mechanisms from oxidative damage becomes attenuated, and extracellular glutamate concentration may increase to neurotoxic levels.
Pharmacologic protection of neurons during regional ischemia continues to be a sought after goal of neuroanesthesiologists. Drugs that act on astrocytes may be useful for this purpose, particularly because these nonneuronal cells clear the excitatory transmitter, glutamate, from the brains extracellular fluid. Glutamate is removed from synaptic spaces by high-affinity, Na- and proton-dependent transporters (EAAT1 and EAAT2) located on astrocytes (1). During ischemia-reperfusion, reactive oxygen species impair this clearance mechanism (1) and the extracellular glutamate concentration increases to excitotoxic levels that kill neurons and expand infarct volume (2). Astrocytes undergo intracellular acidification during ischemia-reperfusion in situ (3) or exposure to oxidative stress in vitro (4). Acidification of intracellular pH (pHi) to values <7.0 inhibits astrocytic glutamate uptake (5) and pHi <6.5 increases infarct volume (6).
Propofol (2,6-diisopropylphenol) is an IV anesthetic and sedative that dose-dependently increases the survival of brain cells and enhances neurologic outcome in experimental stroke (79). Propofols structure differs from other hypnotic sedatives, but resembles the native antioxidant The Na/H exchanger isoform 1 (NHE1), Na/HCO3 cotransporter, and Cl/HCO3 exchanger are the predominant transporters regulating pHi in astrocytes (Fig. 1) (3,1518). Protons accumulating in cytosol interact with a sensor site of NHE1 to promote exchange of protons for Na across the plasma membrane. NHE1 is evidently important for brain function, because NHE1-deficient mice develop ataxia and epilepsy (19,20). NHE1 activity can be blocked selectively with amiloride analogs, such as 5-(N-ethyl-N-isopropyl) amiloride (EIPA). EIPA abolishes the recovery of pHi from an acid load when astrocytes are incubated in bicarbonate-free medium but not in medium containing a physiologic concentration of bicarbonate (16).
Our purpose was to evaluate the hypothesis that propofol protects NHE1 activity and thereby sustains pHi-sensitive glutamate uptake by astrocytes during oxidant stress. Glutamate uptake rate, pHi, and intracellular glutathione (GSH) concentration were measured in primary cultures of rat astrocytes exposed to t-BOOH and propofol. NHE1 antagonists and bicarbonate were used to manipulate pHi. Additionally, comparisons were made between propofol and vitamin E, because this vitamin suppresses lipid peroxidation by t-BOOH (12).
L-[3H]Glutamic acid (3846 Ci/mmol) was purchased from Amersham Canada (Oakville, Ontario, Canada). 2',7'-Biscarboxyethyl carboxyfluorescein (BCECF) acetoxymethyl ester was from Molecular Probes (Eugene, OR). -Tocopherol, t-BOOH, EIPA, and L-glutamate were purchased from Sigma Chemical Company (St. Louis, MO). Horse serum was obtained from Gibco Laboratories (Burlington, Ontario, Canada). Propofol was purchased from Aldrich Chemical Company (Oakville, Ontario, Canada). Propofol and -tocopherol were dissolved in ethanol, whereas EIPA was dissolved in dimethylsulfoxide (DMSO). Control cultures received the same concentration of each vehicle (ethanol 3 µL/mL or DMSO 0.2 µL/mL) as did the drug-treated cultures.
Cell Cultures
Experimental Procedures The initial rate of Na-dependent glutamate uptake (100 µM, 10 mCi/mmol, 1 min) was measured for astrocytes in 60-mm culture dishes according to the procedure we described previously (14). The radioactive cell contents and media aliquots were analyzed by liquid scintillation counting. Uptake rates were expressed per gram cell protein, which was measured by the Lowry method. Experiments in which t-BOOH decreased glutamate uptake by <50% were excluded from further analysis. Na-glutamate cotransport rates were calculated as the difference between total and Na-independent (N-methyl-D-glucamine substituted for Na as the principal cation in the medium) rates of glutamate uptake. Intracellular GSH concentration was determined by a published method (14). For measurement of Na/H exchange rate, primary astrocytes on coverslips were incubated with BCECF-acetoxymethyl ester (5 µg/mL) under serum-free conditions, as described by Dixon and Wilson (17). Microscopic examination confirmed that predominantly cytosolic loading of the pH-sensitive probe, BCECF, was achieved. pHi was monitored continuously at excitation wavelengths of 440 nm and 490 nm with emission wavelength of 530 nm. NHE1 activity was determined by measuring the rate of pHi recovery after acute acid loading by the ammonium chloride prepulse method. The fluorescence ratio was calibrated for each cell culture by using nigericin and an appropriate range of extracellular pH, as we described previously (17). Numerical data were expressed as the mean ± SEM values for n number of experiments with triplicate replications. Analysis of variance with the Tukey-Kramer multiple comparison test or Students paired t-test (two-tailed) was used to evaluate the effects of treatments. A P value < 0.05 was considered significant.
The principal cellular sites of action for the drugs used in this study are indicated in Figure 1. We observed that in nominally bicarbonate-free medium, oxidative stress of primary astrocyte cultures by the cell-permeant initiator of lipid peroxidation, t-BOOH (300 µM for 30 min, followed by a 30-min washout period), decreased the initial rate of Na-dependent glutamate uptake (Fig. 2). The NHE antagonist EIPA (1 µM, 90 min) did not alter glutamate uptake in control or t-BOOH astrocytes. Delayed administration of 18 µM propofol, during the 30-min washout period, attenuated the inhibitory effect of t-BOOH. However, 1 µM EIPA (Fig. 2) abolished protection of glutamate transport by 1 µM propofol. Increasing the propofol concentration to 8 µM overcame this injurious effect of EIPA (Fig. 2). Like propofol, delayed administration of vitamin E during the 30-min washout period was observed to rescue astrocyte glutamate transport from t-BOOH-induced inhibition (Fig. 3). EIPA (1 µM) abolished this protection for 40 µM vitamin E but not for 200 µM vitamin E.
In subsequent experiments, we investigated the mechanism by which EIPA abolished protection by 1 µM propofol in oxidatively stressed astrocytes. These astrocytes were grown in the absence of vitamin C and did not contain ascorbate (data not shown). However, the cells contained abundant GSH that could function as an antioxidant in the aqueous phase. Exposure to t-BOOH was observed to decrease intracellular GSH concentration (Fig. 4). Propofol had no effect on intracellular GSH in the presence or absence of EIPA, indicating that its antioxidant action occurred principally in membranes (Fig. 4).
Next we examined the effect of bicarbonate, because bicarbonate transport can contribute to pHi regulation even when NHE1 is blocked (16). Glutamate uptake was still inhibited by t-BOOH and protected by propofol when astrocytes were incubated in medium containing 25 mM bicarbonate (Fig. 5). However, bicarbonate allowed 1 µM propofol to rescue glutamate uptake while NHE1 activity was blocked by EIPA (Fig. 5).
Fluorescence microscopy of BCECF-loaded astrocytes was used to monitor pHi recovery from an acid load under nominally bicarbonate-free conditions (Fig. 6). We observed that EIPA blocked pHi recovery from acute acidification, thus confirming the predominant role of NHE1 for pHi regulation when bicarbonate is lacking. t-BOOH also inhibited NHE1-mediated pHi recovery. However, propofol prevented NHE1 inhibition by t-BOOH (Fig. 6).
There was no effect of t-BOOH, propofol, vitamin E, EIPA, or bicarbonate on the total cell protein content, indicating that these agents did not cause the astrocytes to lyse or detach (data not shown).
We investigated for the first time the role of pHi in propofol protection of high-affinity glutamate uptake. To the clinician, this line of investigation is important because failure of the glutamate uptake system to clear glutamate from the extracellular fluid leads to excitotoxic killing of neurons (1,2). Glutamate clearance is mediated principally by astrocytes but these cells are compromised by the oxidative stress that accompanies ischemia and reperfusion. Oxidative stress in astrocytes depletes adenosine triphosphate (ATP), inhibits Na,K-adenosine triphosphatase, and increases intracellular levels of both Na and protons (4). The present study indicates that clinical concentrations of propofol prevent inhibition by oxidants of glutamate uptake into astrocytes, whether or not a physiologic level of bicarbonate is present. This effect of propofol may accelerate clearance of the transmitter from synaptic clefts and thereby prevent excitotoxic killing of neurons. The same effect was also seen with vitamin E, which is an endogenous scavenger of lipophilic radicals and inhibitor of lipid peroxidation in membranes. The qualitatively similar improvement in cell function achieved by propofol and vitamin E is consistent with measurements of lipid peroxidation in isolated membranes showing that propofol can replace the vitamin as an antioxidant (10,13). Propofol does not prevent t-BOOH-induced GSH depletion (14). These findings are consistent with the view that propofols antioxidant effect, like that of vitamin E, occurs in membranes and not in the aqueous phase of intact cells. Blockade of Na/H exchange by EIPA was not protective itself and interfered with propofol rescue under bicarbonate-free conditions. In bicarbonate medium, EIPA had no effect on propofol rescue of glutamate transport from peroxyl inhibition. This result suggests EIPA only inhibits glutamate uptake in oxidatively stressed cells if they cannot use bicarbonate to regulate pHi. The transmembrane gradient of protons is important for high-affinity glutamate uptake because the influx of glutamate through EAAT1 and EAAT2 requires the cotransport of protons as well as Na (1). In astrocytes incubated with t-BOOH and propofol under bicarbonate-free conditions, EIPA-sensitive NHE1 activity keeps the intracellular concentration of protons small enough to avoid impairment of glutamate uptake. Although we did not observe protection of glutamate uptake by EIPA, NHE1 antagonists may increase the brains resistance to ischemia-reperfusion injury by attenuating extracellular acidification, endothelial cell swelling, and neutrophil activation (2124). We found that increasing the propofol concentration overcame the deleterious effect of EIPA on glutamate uptake in oxidatively stressed astrocytes. Similarly, neurologic outcome after cerebral ischemia-reperfusion in rats is superior with large-dose propofol than with smaller doses (8). NHE1-mediated Na/H exchange can be activated by intracellular acidification in astrocytes that have not been oxidatively stressed (3,1518), but the response of NHE1 to acid loading is decreased acutely in cells exposed to t-BOOH and other oxidants [Refs. (2527) and present experiments]. A novel finding of our study is that propofol maintains the response of NHE1 to acid loading during oxidative stress and may thereby mitigate intracellular acidification. Propofol may act through several mechanisms to preserve NHE1 activity in cells exposed to t-BOOH. First, propofol inhibits lipid peroxidation, with concentrations as small as 2 µM having been found effective in microsomal suspensions containing GSH (10,11). Second, astrocytic NHE1 activity is dependent on intracellular ATP (18) and propofol may prevent ATP depletion by t-BOOH. Third, propofols blockade of Na channels (28) and maintenance of Na,K-adenosine triphosphatase activity may prevent cytosolic Na concentration from increasing to levels that inhibit NHE1. Finally, propofol may modulate regulator sites in NHE1 and thereby activate Na-H exchange. In conclusion, the present study is consistent with the view that regulation of pHi contributes to neuroprotection by the lipophilic antioxidants, propofol, and vitamin E. Propofol concentrations associated with anesthesia and neuroprotection prevented t-BOOH-induced inhibition of pHi recovery by astrocytes after an acid load. This finding suggests that propofol prevents intracellular acidification during oxidative stress by preserving NHE1 responsiveness to cytosolic protons. However, if intracellular acidification occurs nonetheless, then protection of high-affinity glutamate uptake activity by lipophilic antioxidants becomes attenuated and extracellular glutamate concentration may increase to neurotoxic levels.
The assistance of Ewa Jaworski in preparing cell cultures is gratefully acknowledged.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|